AAH - Stock Analysis for ARANA THERAPEUTICS LTD
You can analyze US and non-US stocks at stock2own.com for FREE.
AU:AAH (SYDNEY)
Calculate financial ratios, growth rates, sticker price and margin of safety (MOS) for Arana Therapeutics Ltd, get Technical Indicators Charts such as moving averages, slow and fast stochastics, MACD for AAH - Arana Therapeutics Ltd.
Business Summary
- Company's web: http://www.arana.com/
- Stock Exchange: SYDNEY
- Industry: Miscellaneous
- Market Capitalization: 192.69 Mil
- Institutional Ownership: NA
- Total Shares Outstanding: 235.0 Mil
- Average Daily Volume: 0.45195 Mil.
- Full Time Employees: 21
- Next Earnings Release: N/A
Arana Therapeutics Limited (Arana) is engaged in the commercialization of research, development, investment in, and licensing of technology, and the formulation, manufacture and marketing of protein-based products for the pharmaceutical industry. ART621 is a new type of therapeutic protein, which incorporates a domain antibody (dAb) and is the first compound incorporating a domain antibody to be used in human trials. PMX53 is a complement 5a (C5a) inhibitor. Arana has developed a new antibody candidate, ART 123 targeting the inflammatory diseases. ART010 is aimed at treating the side-effects of cancer known as cancer-related bone loss. ART104 is an antibody in development for the treatment of colorectal cancer. ART150 is an antibody under development for the treatment of lung cancer and melanoma. Arana has a protein engineering technology platform that incorporates the Company�s Superhumanisation, Synhumanisation and EvoGene technologies.
Growth Rates
- Equity Growth Rate: bad
- EPS Growth Rate: bad
- Sales Growth Rate: bad
- Free Cash Flow Growth Rate: bad
- Cash from Operation Activities Growth Rate: bad
- ROIC Growth Rate: bad
Debt/Free Cash Flow Ratio
Read more about The Rule on Debt in the Theory Section
Debt/FCF ratio is 0 - GOOD
Zero Debt/Free Cash Flow ratio means company does not have long term debt as of latest financial statement.
Negative Debt/Free Cash Flow ratio means company has a negative Free Cash Flow and probably will not be able to pay off its long term debt. There is certainly a problem.
Debt/Free Cash Flow ratio less than 3 means company potentially can pay off its long term debt in less than 3 years, which is OK.
Debt/Free Cash Flow ratio more than 3 means company will not be able to pay off its long term debt in 3 years, which can be a problem. This is not a good sign.
Sticker and MOS Price
Read more about used computation algorithms in the Theory Section
- Sticker Price (intrinsic value) based on 5 year projection: 0
- Margin of Safety (MOS) Price based on 5 year projection: 0
- Sticker Price (intrinsic value) based on 10 year projection: 0
- Margin of Safety (MOS) Price based on 10 year projection: 0
Technical Indicators (The Three Tools)
Read more about Technical Indicators in the Theory Section
The Three Tools are: Moving Average, Stochastics and MACD.